SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices approach all-time highs, fueled by speculation around potential Fed rate cuts and renewed interest in precious metals as a hedge against economic uncertainty. Community members are discussing technical breakouts, potential for a silver squeeze, and historical inflation-adjusted valuations, while some express concerns about market manipulation and potential pullbacks. The broader context involves increased industrial demand for silver and its role as a safe-haven asset amid global economic concerns.

Abaxx Technologies, Inc. development-stage financial technology company, which develops software tools that enable commodity traders and finance professionals to communicate trade and transact faster and more securely. Its software technologies include deep learning and natural language processing (DL/NPL), self-sovereign digital identity (SSI), encrypted content-addressing distributed file systems, smart contracting languages and protocols, and decentralized datastore technology (DDS). The company was founded by Joshua Dale Crumb, Thomas McMahon and Andrew Fedak on January 25, 2018 and is headquartered in Toronto, Canada.

Abaxx Technologies Inc

Recent news and partnerships are driving interest in Abaxx, with community members pointing to its potential to disrupt commodity markets. Many are drawing comparisons to Nvidia and Palantir, highlighting the company's innovative approach and future growth potential. The discussion also revolves around the anticipation of upcoming milestones and the impact on the stock's valuation.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is trending due to discussions around options trading strategies, potential undervaluation, and analyst ratings. Community members are weighing the company's stability against its risk profile compared to peers like ExxonMobil, while also considering its dividend yield as a factor for investment. Option traders are actively discussing potential entry and exit points.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

$BOTZ is trending as investors weigh the potential of AI and robotics against concerns of a possible tech bubble and broader economic weakness. Discussions revolve around the ETF's key holdings, including NVDA, and its exposure to the US-China AI arms race, with community members analyzing its long-term growth prospects.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

XOP is trending amid geopolitical tensions and shifting supply dynamics, with potential impacts from Iranian oil exports and OPEC+ production decisions driving market speculation. Community members are weighing the possibilities of further output cuts and debating the sector's undervaluation. Bullish investors are monitoring the ETF for potential breakouts, while others are cautious about demand in China and wider economic factors.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley ($MS) is trending amid discussions around bank regulations, potential M&A activity, and analysts weighing in on its financial outlook and strategic shifts. The community is focused on institutional ownership, potential earnings catalysts, and its position relative to competitors like Goldman Sachs ($GS). Recent news includes Morgan Stanley expanding crypto access and analysts adjusting price targets, driving both bullish and bearish sentiment.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is trending as the community discusses its long-term potential, interoperability and recent supply cap implementation.  Some investors view it as a solid project for cross-chain applications, while others are weighing its potential against emerging Layer 1 solutions focused on high-speed settlement and compliance.

SSgA Active Trust - Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund

The Health Care Select Sector SPDR Fund ($XLV) is trending amid discussions of sector rotation and potential breakout opportunities, particularly as some analysts suggest a shift from technology into healthcare. Community members are actively trading call options on XLV, targeting higher price levels, while also weighing in on potential impacts from healthcare policy and individual companies within the sector. There is also discussion that a recent top may need to be retested.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as the community digests mixed earnings results, with streaming growth offset by declines in linear TV. Community discussion also centers on Disney's ongoing dispute with YouTube TV and potential impacts from upcoming movie releases like Zootopia 2. Despite some bearish sentiment, analysts are weighing in with price target adjustments, and some investors are seeing a buying opportunity.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is trending amid mixed community sentiment, with some investors expressing frustration over its performance compared to Bitcoin and other altcoins. Discussions include analysis of Cardano's technology and future potential, as well as comparisons to emerging competitors; some traders anticipate a market reversal, while others believe a crypto winter is imminent.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Valneva (NASDAQ:VALN) Sees Strong Trading Volume - Here's What Happened

Valneva (NASDAQ:VALN) Sees Strong Trading Volume - What's Next...

Valneva's Lyme Vaccine VLA15 Shows Strong Phase 2 Booster Results With Favorable Safety

(RTTNews) - Valneva SE (VALN) announced positive final immunogenicity and safety data from its Phase 2 study, VLA15-221, evaluating the Lyme disease vaccine candidate VLA15. The study results...

Valneva (NASDAQ:VALN) Releases Earnings Results, Misses Estimates By $0.31 EPS

Valneva (NASDAQ:VALN - Get Free Report) announced its earnings results on Thursday. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.30) by...

Valneva (NASDAQ:VALN) Stock Price Up 3.4% - Time to Buy?

Valneva (NASDAQ:VALN) Stock Price Up 3.4% - Should You Buy...

Valneva (VALN) Projected to Post Earnings on Thursday

Valneva (NASDAQ:VALN) will be releasing its Q3 2025 earnings before the market opens on Thursday, November 20. (View Earnings Report at...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN...

Analysts on Monday expressed divergent opinions on vaccine company Valneva SE (VALN) after the firm said that the United States Food and Drug Administration (FDA) has suspended the license for its Chikungunya vaccine Ixchiq. Shares of Valneva tumbled over 19% on Monday.Jefferies analyst Maury Raycroft lowered the firm's price target on Valneva to $14 from $18 while keeping a ‘Buy’ rating on the shares following the news. The firm, which thinks there is some potential risk for ex-U.S. regulators to change their stance on Ixchiq licensure, added that Ixchiq is "not a major revenue driver" in the near term, according to TheFly.H.C. Wainwright analyst Brandon Folkes, meanwhile, reiterated a ‘Buy’ rating on Valneva. Despite the FDA's decision, Valneva has not revised its revenue guidance for 2025, the analyst noted. The stock selloff on Monday offers an attractive entry for investors who are constructive on a potential positive readout for VLA15, the company’s investigational Lyme disease vaccine, later this year, contends H.C. Wainwright. The firm views the selloff as overdone and keeps an $18 price target on Valneva, TheFly noted.On Stocktwits, retail sentiment around Valneva remained within ‘bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_25_at_12_45_54_PM_png_bbe73f8bfa.webp" alt="VALN's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Aug. 25, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>VALN's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Aug. 25, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user remains hopeful about the company getting acquired.<stembedurl>https://stocktwits.com/Papusa/message/626441643</stembedurl>Another, meanwhile, said that they are cutting their risk.<stembedurl>https://stocktwits.com/nroberts7/message/626439114</stembedurl>Valneva <a target="_blank" rel="noopener noreferrer nofollow" href="https://valneva.com/wp-content/uploads/2025/08/2025_08_25_FDA_IXCHIQ_Update_PR_EN_Final2.pdf">said</a> on Monday that the FDA suspended the license for Ixchiq in the U.S., citing four new reports of serious adverse events consistent with chikungunya-like illness. The suspension, it said, is effective immediately and requires the company to stop shipping and selling Ixchiq in the U.S.All four cases occurred outside the U.S., the company said. While three cases occurred in individuals aged 70 to 82 years, one case occurred in a 55-year-old individual. The company also said that an 82-year-old was hospitalized and discharged after two days.The firm said it believes all cases describe symptoms consistent with those reported during clinical trials, but added that it is continuing to investigate these cases in detail and will pursue further steps about the FDA’s decision if warranted.The company also said that it is evaluating the financial impact of the withdrawal of Ixchiq’s license in the U.S. However, it did not modify its revenue guidance. In the first half of 2025, Ixchiq contributed €7.5 million ($8.74 million) to the company’s €91 million total product sales.VALN stock is up by 116% this year and by about 18% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-exec-hints-at-possible-price-hike-on-model-y-in-us/chsssVVRdSR">Tesla Executive Hints At Possible Price Hike On Model Y In US: Retail Highlights Negative Catalysts</a>For updates and corrections, email newsroom[at]stocktwits[dot]comExchange Rate: €1= $1.16

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the Valneva logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

Valneva Stock Tumbles 19% After FDA Suspension Of Ixchiq License In US, Wall Street Divided On The Impact

While Jefferies lowered its price target on Valneva, H.C. Wainwright kept its $18 price target unchanged. 

Equity

While Jefferies lowered its price target on Valneva, H.C. Wainwright kept its $18 price target unchanged. 



Valneva (VALN) Soars 17.4%: Is Further Upside Left in the Stock?

Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Valneva SE (VALN, $7.68) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that VALN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Valneva SE - ADR

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.33	--	--	N/A
Q3 '25	-$0.33	-$0.30	7.07%	BEAT
Q2 '25	-$0.28	-$0.16	41.35%	BEAT
Q1 '25	-$0.28	--	--	N/A
Q4 '24	-$0.19	--	--	N/A

VALN
Valneva SE - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest VALN News

VALNValneva SE - ADR